NuVasive announced the U.S. launch of AttraX® Putty, the newest product in its biologics portfolio.
AttraX Putty is a next generation, synthetic bone graft product intended for use as an autograft extender in the posterior lateral spine. The biotextured™ surface features of AttraX Putty help to regenerate bone, demonstrated in pre-clinical studies when compared to traditional osteoconductive synthetic scaffolds.
Source: NuVasive, Inc.
NuVasive announced the launch of AttraX Putty and four other technologies earlier this quarter at the annual American Association of Neurological Surgeons meeting.